InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the complete record of transactions filed by Gloria Melanie, Chief Operating Officer. Director active across 1 companies, notably Immunovant, Inc.. In total, 4 filings have been published. Total volume traded: €437k. The latest transaction was disclosed on 8 April 2026 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations4 total
US$185,7458,722 shares@ US$21.29620.0033% mcap84.9% of flow
Common Stock
SEC:0001973838-26-000004·
€185,7458,722 shares@ €21.29620.0033% mcap42.5% of flow
Common Stock
SEC:0001973838-26-000004:0·
US$32,9251,437 shares@ US$22.91250.0006% mcap15.1% of flow
Common Stock
SEC:0001764013-26-000013·
€32,9251,437 shares@ €22.91250.0006% mcap7.5% of flow
Common Stock
SEC:0001764013-26-000013:0·
4 of 4 declarations
About Gloria Melanie
Gloria Melanie is the Chief Operating Officer at Immunovant, Inc. She is responsible for managing the daily operations of the company, ensuring efficiency and alignment of activities with strategic objectives. Her role also involves overseeing teams and implementing innovative solutions to enhance the company's performance in the biotechnology sector.
